Onychomycosis Treatment Market Report

Global and Region Onychomycosis Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：226
  • REPORT CODE：GMM900630
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Onychomycosis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Onychomycosis Treatmentmarket, defines the market attractiveness level of Onychomycosis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Onychomycosis Treatment industry, describes the types of Onychomycosis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Onychomycosis Treatment market and the development prospects and opportunities of Onychomycosis Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Onychomycosis Treatment market in Chapter 13.

    By Player:

    • Viatris Inc

    • GlaxoSmithKline plc

    • Sanofi SA

    • Cipla Ltd

    • Teva Pharmaceutical Industries Ltd

    • Moberg Pharma AB

    • Cardinal Health, Inc

    • Dr Reddy’s Laboratories Ltd

    • Valent Pharmaceutical

    • Almirall, SA

    • Novartis AG

    • Johnson & Johnson

    • Pfizer Inc

    • Bayer AG

    • Galderma

    By Type:

    • Medication

    • Lasers

    • Photodynamic Therapy

    By End-User:

    • Hospitals

    • Dermatology Clinics

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Onychomycosis Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Onychomycosis Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Onychomycosis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Onychomycosis Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Onychomycosis Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Onychomycosis Treatment Consumption (2017-2022)

    • 7.2 United States Onychomycosis Treatment Consumption (2017-2022)

    • 7.3 Europe Onychomycosis Treatment Consumption (2017-2022)

    • 7.4 China Onychomycosis Treatment Consumption (2017-2022)

    • 7.5 Japan Onychomycosis Treatment Consumption (2017-2022)

    • 7.6 India Onychomycosis Treatment Consumption (2017-2022)

    • 7.7 South Korea Onychomycosis Treatment Consumption (2017-2022)

    8 Region and Country-wise Onychomycosis Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Onychomycosis Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Onychomycosis Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Onychomycosis Treatment Consumption Forecast (2022-2028)

    • 8.4 China Onychomycosis Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Onychomycosis Treatment Consumption Forecast (2022-2028)

    • 8.6 India Onychomycosis Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Onychomycosis Treatment Consumption Forecast (2022-2028)

    9 Global Onychomycosis Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Onychomycosis Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Medication Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lasers Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Photodynamic Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Onychomycosis Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Dermatology Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Onychomycosis Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Onychomycosis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Medication Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lasers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Photodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Onychomycosis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Dermatology Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Onychomycosis Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Onychomycosis Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Onychomycosis Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Onychomycosis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Onychomycosis Treatment Market Competitive Analysis

    • 14.1 Viatris Inc

      • 14.1.1 Viatris Inc Company Details

      • 14.1.2 Viatris Inc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Viatris Inc Onychomycosis Treatment Product and Service

    • 14.2 GlaxoSmithKline plc

      • 14.2.1 GlaxoSmithKline plc Company Details

      • 14.2.2 GlaxoSmithKline plc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline plc Onychomycosis Treatment Product and Service

    • 14.3 Sanofi SA

      • 14.3.1 Sanofi SA Company Details

      • 14.3.2 Sanofi SA Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi SA Onychomycosis Treatment Product and Service

    • 14.4 Cipla Ltd

      • 14.4.1 Cipla Ltd Company Details

      • 14.4.2 Cipla Ltd Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Cipla Ltd Onychomycosis Treatment Product and Service

    • 14.5 Teva Pharmaceutical Industries Ltd

      • 14.5.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.5.2 Teva Pharmaceutical Industries Ltd Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceutical Industries Ltd Onychomycosis Treatment Product and Service

    • 14.6 Moberg Pharma AB

      • 14.6.1 Moberg Pharma AB Company Details

      • 14.6.2 Moberg Pharma AB Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Moberg Pharma AB Onychomycosis Treatment Product and Service

    • 14.7 Cardinal Health, Inc

      • 14.7.1 Cardinal Health, Inc Company Details

      • 14.7.2 Cardinal Health, Inc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cardinal Health, Inc Onychomycosis Treatment Product and Service

    • 14.8 Dr Reddy’s Laboratories Ltd

      • 14.8.1 Dr Reddy’s Laboratories Ltd Company Details

      • 14.8.2 Dr Reddy’s Laboratories Ltd Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Dr Reddy’s Laboratories Ltd Onychomycosis Treatment Product and Service

    • 14.9 Valent Pharmaceutical

      • 14.9.1 Valent Pharmaceutical Company Details

      • 14.9.2 Valent Pharmaceutical Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Valent Pharmaceutical Onychomycosis Treatment Product and Service

    • 14.10 Almirall, SA

      • 14.10.1 Almirall, SA Company Details

      • 14.10.2 Almirall, SA Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Almirall, SA Onychomycosis Treatment Product and Service

    • 14.11 Novartis AG

      • 14.11.1 Novartis AG Company Details

      • 14.11.2 Novartis AG Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis AG Onychomycosis Treatment Product and Service

    • 14.12 Johnson & Johnson

      • 14.12.1 Johnson & Johnson Company Details

      • 14.12.2 Johnson & Johnson Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Johnson & Johnson Onychomycosis Treatment Product and Service

    • 14.13 Pfizer Inc

      • 14.13.1 Pfizer Inc Company Details

      • 14.13.2 Pfizer Inc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Pfizer Inc Onychomycosis Treatment Product and Service

    • 14.14 Bayer AG

      • 14.14.1 Bayer AG Company Details

      • 14.14.2 Bayer AG Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Bayer AG Onychomycosis Treatment Product and Service

    • 14.15 Galderma

      • 14.15.1 Galderma Company Details

      • 14.15.2 Galderma Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Galderma Onychomycosis Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Onychomycosis Treatment

    • Figure Onychomycosis Treatment Picture

    • Table Global Onychomycosis Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Onychomycosis Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Onychomycosis Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Onychomycosis Treatment Consumption by Country (2017-2022)

    • Figure United States Onychomycosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Onychomycosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Onychomycosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Onychomycosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Onychomycosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Onychomycosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Onychomycosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Onychomycosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Onychomycosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Onychomycosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Onychomycosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Onychomycosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Onychomycosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medication Consumption and Growth Rate (2017-2022)

    • Figure Global Lasers Consumption and Growth Rate (2017-2022)

    • Figure Global Photodynamic Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Dermatology Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Medication Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lasers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Photodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dermatology Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Onychomycosis Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Onychomycosis Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Viatris Inc (Foundation Year, Company Profile and etc.)

    • Table Viatris Inc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Viatris Inc Onychomycosis Treatment Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Onychomycosis Treatment Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Onychomycosis Treatment Product and Service

    • Table Cipla Ltd (Foundation Year, Company Profile and etc.)

    • Table Cipla Ltd Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Ltd Onychomycosis Treatment Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Onychomycosis Treatment Product and Service

    • Table Moberg Pharma AB (Foundation Year, Company Profile and etc.)

    • Table Moberg Pharma AB Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moberg Pharma AB Onychomycosis Treatment Product and Service

    • Table Cardinal Health, Inc (Foundation Year, Company Profile and etc.)

    • Table Cardinal Health, Inc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health, Inc Onychomycosis Treatment Product and Service

    • Table Dr Reddy’s Laboratories Ltd (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy’s Laboratories Ltd Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy’s Laboratories Ltd Onychomycosis Treatment Product and Service

    • Table Valent Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Valent Pharmaceutical Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valent Pharmaceutical Onychomycosis Treatment Product and Service

    • Table Almirall, SA (Foundation Year, Company Profile and etc.)

    • Table Almirall, SA Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almirall, SA Onychomycosis Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Onychomycosis Treatment Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Onychomycosis Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Onychomycosis Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Onychomycosis Treatment Product and Service

    • Table Galderma (Foundation Year, Company Profile and etc.)

    • Table Galderma Onychomycosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma Onychomycosis Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US